The Portuguese version of the Clinical Global Impression - Schizophrenia Scale: validation study

OBJECTIVES: The Clinical Global Impression - Schizophrenia Scale was designed to assess severity and treatment response in subjects with schizophrenia involved in naturalistic studies and daily clinical practice. The objective of this study is to validate the Portuguese version of the Clinical Global Impression - Schizophrenia Scale in Brazil by assessing its psychometric properties. METHOD: Cross-sectional validation study of the Portuguese version of the Clinical Global Impression - Schizophrenia Scale, tested in outpatients and inpatients with schizophrenia (DSM-IV, ICD-10) from 6 centers in Brazil. Concurrent validity and sensitivity to change were assessed by comparison with the Positive and Negative Syndrome Scale, which is considered the gold standard tool to evaluate patients with schizophrenia. Interrater reliability was evaluated by intraclass correlation coefficients (ICC) calculated based on the scoring of two concomitant raters. RESULTS: 70 inpatients and 70 outpatients were evaluated. Total Clinical Global Impression - Schizophrenia Scale and Positive and Negative Syndrome Scale scores were highly correlated (r = 0.79; p < 0.01). Positive (r = 0.86), negative (r = 0.79), depressive (r = 0.66) and cognitive (r = 0.75) symptoms subscale scores were also correlated between both scales (p < 0.01). Sensitivity to change was significantly correlated between the Clinical Global Impression - Schizophrenia Scale and Positive and Negative Syndrome Scale (r = 0.73; p < 0.01). Interrater reliability was substantial for positive symptoms and total scores of the Clinical Global Impression - Schizophrenia Scale (ICC = 0.81 and 0.73), and moderate for negative, depressive, and cognitive symptoms score (0.64, 0.67 and 0.63, respectively). CONCLUSIONS: The Brazilian version of the Clinical Global Impression - Schizophrenia Scale is a valid and reliable instrument for the assessment of severity and treatment response in schizophrenic inpatient and outpatients.

Saved in:
Bibliographic Details
Main Authors: Lima,Maurício Silva de, Soares,Bernardo Garcia de Oliveira, Paoliello,Gilda, Vieira,Rodrigo Machado, Martins,Cláudio Meneghello, Mota Neto,Joaquim Ignácio da, Ferrão,Ygor, Schirmer,Douglas Allen, Volpe,Fernando Madalena
Format: Digital revista
Language:English
Published: Associação Brasileira de Psiquiatria 2007
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462007000300010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-44462007000300010
record_format ojs
spelling oai:scielo:S1516-444620070003000102007-11-27The Portuguese version of the Clinical Global Impression - Schizophrenia Scale: validation studyLima,Maurício Silva deSoares,Bernardo Garcia de OliveiraPaoliello,GildaVieira,Rodrigo MachadoMartins,Cláudio MeneghelloMota Neto,Joaquim Ignácio daFerrão,YgorSchirmer,Douglas AllenVolpe,Fernando Madalena Schizophrenia Psychiatric status rating scales Validity of tests Validation studies Multicenter study OBJECTIVES: The Clinical Global Impression - Schizophrenia Scale was designed to assess severity and treatment response in subjects with schizophrenia involved in naturalistic studies and daily clinical practice. The objective of this study is to validate the Portuguese version of the Clinical Global Impression - Schizophrenia Scale in Brazil by assessing its psychometric properties. METHOD: Cross-sectional validation study of the Portuguese version of the Clinical Global Impression - Schizophrenia Scale, tested in outpatients and inpatients with schizophrenia (DSM-IV, ICD-10) from 6 centers in Brazil. Concurrent validity and sensitivity to change were assessed by comparison with the Positive and Negative Syndrome Scale, which is considered the gold standard tool to evaluate patients with schizophrenia. Interrater reliability was evaluated by intraclass correlation coefficients (ICC) calculated based on the scoring of two concomitant raters. RESULTS: 70 inpatients and 70 outpatients were evaluated. Total Clinical Global Impression - Schizophrenia Scale and Positive and Negative Syndrome Scale scores were highly correlated (r = 0.79; p < 0.01). Positive (r = 0.86), negative (r = 0.79), depressive (r = 0.66) and cognitive (r = 0.75) symptoms subscale scores were also correlated between both scales (p < 0.01). Sensitivity to change was significantly correlated between the Clinical Global Impression - Schizophrenia Scale and Positive and Negative Syndrome Scale (r = 0.73; p < 0.01). Interrater reliability was substantial for positive symptoms and total scores of the Clinical Global Impression - Schizophrenia Scale (ICC = 0.81 and 0.73), and moderate for negative, depressive, and cognitive symptoms score (0.64, 0.67 and 0.63, respectively). CONCLUSIONS: The Brazilian version of the Clinical Global Impression - Schizophrenia Scale is a valid and reliable instrument for the assessment of severity and treatment response in schizophrenic inpatient and outpatients.info:eu-repo/semantics/openAccessAssociação Brasileira de PsiquiatriaBrazilian Journal of Psychiatry v.29 n.3 20072007-09-01info:eu-repo/semantics/othertext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462007000300010en10.1590/S1516-44462006005000047
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Lima,Maurício Silva de
Soares,Bernardo Garcia de Oliveira
Paoliello,Gilda
Vieira,Rodrigo Machado
Martins,Cláudio Meneghello
Mota Neto,Joaquim Ignácio da
Ferrão,Ygor
Schirmer,Douglas Allen
Volpe,Fernando Madalena
spellingShingle Lima,Maurício Silva de
Soares,Bernardo Garcia de Oliveira
Paoliello,Gilda
Vieira,Rodrigo Machado
Martins,Cláudio Meneghello
Mota Neto,Joaquim Ignácio da
Ferrão,Ygor
Schirmer,Douglas Allen
Volpe,Fernando Madalena
The Portuguese version of the Clinical Global Impression - Schizophrenia Scale: validation study
author_facet Lima,Maurício Silva de
Soares,Bernardo Garcia de Oliveira
Paoliello,Gilda
Vieira,Rodrigo Machado
Martins,Cláudio Meneghello
Mota Neto,Joaquim Ignácio da
Ferrão,Ygor
Schirmer,Douglas Allen
Volpe,Fernando Madalena
author_sort Lima,Maurício Silva de
title The Portuguese version of the Clinical Global Impression - Schizophrenia Scale: validation study
title_short The Portuguese version of the Clinical Global Impression - Schizophrenia Scale: validation study
title_full The Portuguese version of the Clinical Global Impression - Schizophrenia Scale: validation study
title_fullStr The Portuguese version of the Clinical Global Impression - Schizophrenia Scale: validation study
title_full_unstemmed The Portuguese version of the Clinical Global Impression - Schizophrenia Scale: validation study
title_sort portuguese version of the clinical global impression - schizophrenia scale: validation study
description OBJECTIVES: The Clinical Global Impression - Schizophrenia Scale was designed to assess severity and treatment response in subjects with schizophrenia involved in naturalistic studies and daily clinical practice. The objective of this study is to validate the Portuguese version of the Clinical Global Impression - Schizophrenia Scale in Brazil by assessing its psychometric properties. METHOD: Cross-sectional validation study of the Portuguese version of the Clinical Global Impression - Schizophrenia Scale, tested in outpatients and inpatients with schizophrenia (DSM-IV, ICD-10) from 6 centers in Brazil. Concurrent validity and sensitivity to change were assessed by comparison with the Positive and Negative Syndrome Scale, which is considered the gold standard tool to evaluate patients with schizophrenia. Interrater reliability was evaluated by intraclass correlation coefficients (ICC) calculated based on the scoring of two concomitant raters. RESULTS: 70 inpatients and 70 outpatients were evaluated. Total Clinical Global Impression - Schizophrenia Scale and Positive and Negative Syndrome Scale scores were highly correlated (r = 0.79; p < 0.01). Positive (r = 0.86), negative (r = 0.79), depressive (r = 0.66) and cognitive (r = 0.75) symptoms subscale scores were also correlated between both scales (p < 0.01). Sensitivity to change was significantly correlated between the Clinical Global Impression - Schizophrenia Scale and Positive and Negative Syndrome Scale (r = 0.73; p < 0.01). Interrater reliability was substantial for positive symptoms and total scores of the Clinical Global Impression - Schizophrenia Scale (ICC = 0.81 and 0.73), and moderate for negative, depressive, and cognitive symptoms score (0.64, 0.67 and 0.63, respectively). CONCLUSIONS: The Brazilian version of the Clinical Global Impression - Schizophrenia Scale is a valid and reliable instrument for the assessment of severity and treatment response in schizophrenic inpatient and outpatients.
publisher Associação Brasileira de Psiquiatria
publishDate 2007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462007000300010
work_keys_str_mv AT limamauriciosilvade theportugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT soaresbernardogarciadeoliveira theportugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT paoliellogilda theportugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT vieirarodrigomachado theportugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT martinsclaudiomeneghello theportugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT motanetojoaquimignacioda theportugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT ferraoygor theportugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT schirmerdouglasallen theportugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT volpefernandomadalena theportugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT limamauriciosilvade portugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT soaresbernardogarciadeoliveira portugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT paoliellogilda portugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT vieirarodrigomachado portugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT martinsclaudiomeneghello portugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT motanetojoaquimignacioda portugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT ferraoygor portugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT schirmerdouglasallen portugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
AT volpefernandomadalena portugueseversionoftheclinicalglobalimpressionschizophreniascalevalidationstudy
_version_ 1756422624207962112